OP04. Predicting sites of treatment failure and tumour recurrence in the invasive margin of glioblastomas (PRaM-GBM) - Trial

AIM: The invasive nature of glioblastomas ensures that residual disease is inevitable following surgery. As this cannot be identified with conventional imaging, radiotherapy volumes must include normal brain to treat this occult invasion. We need an imaging biomarker to identify this residual tumour...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Price, Mr Stephen, Matys, Dr Tomasz, Joannides, Dr Alexis, Jena, Dr Raj, Burnet, Prof Neil
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5358556/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now292.003
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia